Moreover, our research elucidates the oncogenic implications of TNFAIP3 in ESCC and its intricate relationship with the crucial transcription factor RARγ, thereby suggesting a promising avenue for future clinical interventions in the treatment of ESCC. The gene discussed is RARG; the disease is esophageal squamous cell carcinoma.